← Every applicant
Sagent FDA Approvals
6 new drug approvals and 0 device clearances on file. This applicant is not matched to a listed company.
Newest first
A new drug approval is an original application; a 510(k) is a device shown equivalent to one already sold.
| Product |
|---|
| NOREPINEPHRINE BITARTRATE IN 5% DEXTROSENew drugMar 26, 2026SOLUTION, INTRAVENOUS |
| CALCIUM GLUCONATE IN SODIUM CHLORIDENew drugDec 30, 2025SOLUTION, INTRAVENOUS |
| NOREPINEPHRINE BITARTRATE IN 5% DEXTROSENew drugAug 11, 2025SOLUTION, INTRAVENOUS |
| FAMOTIDINENew drugJul 16, 2025SOLUTION, INTRAVENOUS |
| CALCITONIN-SALMONNew drugJul 9, 2025INJECTABLE, INJECTION |
| FUROSEMIDENew drugJan 27, 2021INJECTABLE, INJECTION |